Physician profile
Christopher W Chase
NPI 1336197987
$2,169.79
in general payments reported to CMS, 2019-2025
20 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $478 · 2021: $322 · 2022: $246 · 2023: $474 · 2024: $375 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $497.72 | 2020-2022 | |
| Mentor Worldwide LLC | $400.50 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $265.71 | 2022-2025 | Collagenase Santyl |
| Allergan, INC. | $208.82 | 2019-2021 | |
| Revance Therapeutics, INC. | $181.54 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $175.49 | 2020-2025 | |
| Abbvie INC. | $97.46 | 2023-2025 | Botox |
| Pacira Pharmaceuticals Incorporated | $73.88 | 2021-2024 | Exparel, Iovera |
| Integra Lifesciences Corporation | $34.08 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Kowa Pharmaceuticals America, INC. | $31.04 | 2023 | Seglentis |
| Heron Therapeutics, INC. | $27.51 | 2022 | |
| Medline Industries LP | $24.35 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $23.66 | 2025 | |
| Trevena, INC. | $22.90 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $22.33 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $19.44 | 2021 | |
| Coopersurgical, INC. | $17.27 | 2024 | Insorb |
| Tepha INC | $16.64 | 2019 | |
| Motiva USA, LLC | $15.52 | 2024 | |
| Ethicon US, LLC | $13.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.